COMPASS Pathways Plc American Depository Shares (CMPS)
CMPS trades on Nasdaq in Health Care, Biotechnology: Pharmaceutical Preparations. Numbers below come from the Nasdaq screener and SEC filings, each with its source.
Price, change, market cap, sector and industry: Nasdaq stock screener, as of November 16, 2026.
Profile
| Field | Value |
|---|---|
| Ticker | CMPS on Nasdaq |
| Sector | Health Care |
| Industry | Biotechnology: Pharmaceutical Preparations |
| Country | United Kingdom |
| IPO year | 2020 |
| SEC CIK | 0001816590 |
| SEC industry code | Pharmaceutical Preparations |
| Incorporated in | United Kingdom |
Financials
Foreign filer: no machine-readable annual figure in SEC data.
Warning signs
| Sign | Finding | Source |
|---|---|---|
| Going concern | No going-concern finding. | 10-Q 2026-11-03 |
| Cash and burn | $444.0M cash; operating cash flow -$44.2M a quarter. | Report 2026-09-30 |
| Shares outstanding | 141,710,353 (2026-10-28); 96,017,044 a year earlier; 61,896,535 three years earlier. | Cover page 2026-10-28 |
| Reverse splits, 3 years | None found | None on EDGAR |
| Shelf and offerings, 12 months | 1 S-3/F-3 shelf filings; 2 424B5 takedowns, 2 at the market | Latest 2026-02-19 |
| Exchange deficiency notices, 12 months | None | None on EDGAR |
| Auditor | PricewaterhouseCoopers LLP, Boston, Massachusetts, United States; changed auditors 1 time in 24 months | 8-K 4.01 2025-04-16 |
| Late filings, 12 months | None | None on EDGAR |
| Insider trades, 12 months | Bought $0, sold $0 on the open market | SEC Forms 3/4/5 data sets 2026-09-30 |
From SEC EDGAR submissions, EDGAR full-text search, SEC's Forms 3/4/5 data sets and PCAOB Form AP; computed November 16, 2026. Runway is cash divided by average quarterly operating cash burn. Dilution compares cover-page share counts, corrected for recorded splits.
Quarterly results
| Quarter | Revenue | Net income | Op. cash flow | Cash | Total debt | TTM revenue | Source |
|---|---|---|---|---|---|---|---|
| Q3 2026 2026-09-30 | Not filed | -$9.8M | -$50.8M | $444.0M | $51.0M | Needs four quarters | 10-Q 2026-11-03 |
| Q2 2026 2026-06-30 | Not filed | -$253.8M | -$40.3M | $433.3M | $50.7M | Needs four quarters | 10-Q 2026-11-03 |
| Q1 2026 2026-03-31 | Not filed | $91.2M | -$47.9M | $466.0M | $50.5M | Needs four quarters | 10-Q 2026-11-03 |
| Q4 2025 2025-12-31 | Not filed | -$93.9M | -$37.8M | $149.6M | $31.6M | Needs four quarters | 10-K 2026-03-24 |
| Q3 2025 2025-09-30 | Not filed | -$137.7M | -$35.1M | $185.9M | $31.3M | Needs four quarters | 10-Q 2026-11-03 |
| Q2 2025 2025-06-30 | Not filed | -$38.4M | -$38.7M | $221.9M | $30.9M | Needs four quarters | 10-Q 2026-11-03 |
| Q1 2025 2025-03-31 | Not filed | -$17.9M | -$45.7M | $260.1M | $30.5M | Needs four quarters | 10-Q 2026-11-03 |
| Q4 2024 2024-12-31 | Not filed | -$43.3M | -$41.8M | $165.1M | $30.2M | Needs four quarters | 10-K 2026-03-24 |
From SEC XBRL company facts. Quarters a filing gives only as year-to-date are computed as differences (Q4 is the fiscal year minus nine months).
Key SEC documents
| Document | Form | Filed |
|---|---|---|
| Latest prospectus or offering document | S-3ASR | 2026-08-05 |
| Latest annual report | 10-K | 2026-03-24 |
| Latest quarterly / interim | 10-Q | 2026-11-03 |
| Latest current report | 8-K | 2026-11-03 |
| Latest proxy | DEF 14A | 2026-04-15 |
Source: SEC EDGAR submissions feed, 344 recent filings. All filings on EDGAR.
Price moves
| Window | Return |
|---|---|
| 1 week | +4.6% |
| 1 month | -19.1% |
| 3 months | -32.2% |
| Year to date | +30.6% |
| 1 year | +70.3% |
| From 52-week high | -40.7% |
Source: Yahoo Finance daily closes, last bar 2026-11-13. Computed by MarginsX from daily closes; cap, sector and tier from the Nasdaq screener.
Peers in Biotechnology: Pharmaceutical Preparations
| Ticker | Company | Price | Day | Market cap |
|---|---|---|---|---|
| KARD | Kardigan Inc. | $12.85 | -7.02% | $1.2B |
| OPK | OPKO Health Inc. | $1.62 | -3.57% | $1.2B |
| OMER | Omeros Corporation | $16.68 | -4.63% | $1.2B |
| SLN | Silence Therapeutics Plc American Depository Share | $19.80 | -0.15% | $1.2B |
| AAPG | Ascentage Pharma Group International American Depository Shares | $13.29 | -9.10% | $1.2B |
| AMPH | Amphastar Pharmaceuticals Inc. | $29.17 | -0.68% | $1.2B |
| NKTR | Nektar Therapeutics | $36.44 | -2.23% | $1.2B |
| HROW | Harrow Inc. | $29.09 | -3.42% | $1.1B |
The full dossier has every filing, three years of financials, private raises and the people who signed them.
Open the full dossier